Resources

Selected
  • 烽火通讯股价突破30元可能性分析
Type of publications
Regions
Diseases
446 results found
2015 ∙ Demicheli, V. Barale, A. Rivetti, A.
Vaccines for women for preventing neonatal tetanus
Adolescents Adults Pregnant women Tetanus Efficacy/effectiveness Safety Administration
Rating:
High
2015 ∙ STIKO
Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease
Background paper Europe Germany Meningococcal disease
Download:
2015 ∙ Haut Conseil de la santé publique
Opinion concerning the prioritization of the use of antivirals during seasonalinfluenza outbreak
Recommendation Europe France Influenza
Download:
2014 ∙ Prutsky, G. J. Domecq, J. P. Elraiyah, T. Prokop, L. J. Murad, M. H.
Assessing the evidence: Live attenuated influenza vaccine in children younger than 2 years. A systematic review
Newborn Children Influenza Efficacy/effectiveness Safety
Rating:
Critically low
2014 ∙ Yuen, C. Y. S. Tarrant, M.
Determinants of uptake of influenza vaccination among pregnant women - A systematic review
Pregnant women Influenza Acceptance Coverage
Rating:
Not applicable
2014 ∙ Leshem, E. Lopman, B. Glass, R. Gentsch, J. Bányai, K. Parashar, U. Patel, M.
Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: A systematic review and meta-analysis
Newborn Children Rotavirus Efficacy/effectiveness
Rating:
Critically low
2014 ∙ Vasilevska, M. Ku, J. Fisman, D. N.
Factors associated with healthcare worker acceptance of vaccination: A systematic review and meta-analysis
Healthcare workers Acceptance Coverage
Rating:
Not applicable
2014 ∙ Remschmidt, C. Wichmann, O. Harder, T.
Influenza vaccination in HIV-infected individuals: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness and safety
All age groups Influenza Efficacy/effectiveness Safety
Rating:
Low
2014 ∙ Thomas Roger, E. Lorenzetti Diane, L.
Interventions to increase influenza vaccination rates of those 60 years and older in the community
Adults Older adults Influenza Coverage
Rating:
Not applicable
2014 ∙ Cárdenas, G. Soto-Hernández, J. L. Díaz-Alba, A. Ugalde, Y. Mérida-Puga, J. Rosetti, M. Sciutto, E.
Neurological events related to influenza A (H1N1) pdm09
All age groups Influenza Efficacy/effectiveness Safety
Rating:
Critically low
Loading...